Prostate Cancer Clinical Trials in Cleveland

Showing 121-140 of 329 trials

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

NCT06520345

The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with Androgen Receptor Pathway Inhibitor Treatment

Metastatic Castration-resistant Prostate Cancer

Telix Pharmaceuticals (Innovations) Pty Limited430 participantsStarted Jul 2024

Orange, California, United States • Miami, Florida, United States • Glen Burnie, Maryland, United States +12 more locations

Not Yet RecruitingNA< 1 mile

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

NCT07040501

The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.

Prostate Cancer

Case Comprehensive Cancer Center50 participantsStarted Sep 2025

Cleveland, Ohio, United States

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Prostate Cancer Trials in Other Cities

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

MGD019 DART® Protein in Unresectable/Metastatic Cancer

LTFU for All Cell and Gene Therapy Studies

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer

Clinical Trial of Approaches to Prostate Cancer Surgery

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Other Conditions in Cleveland